Vktx nasdaq.

VKTX Price Action: Viking Therapeutics is making new 52-week highs on Monday. The stock was up 46.2% at $5.88 at time of publication, according to Benzinga Pro. Photo: Konstantin Kolosov from Pixabay.

Vktx nasdaq. Things To Know About Vktx nasdaq.

Viking Therapeutics to Participate at Upcoming Investor Conferences PR Newswire SAN DIEGO, Nov. 2, 2023 SAN DIEGO, Nov. 2, 2023...VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.About Viking Therapeutics Stock (NASDAQ:VKTX) Founded in 2012, Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California. The company is focused on developing novel therapies for metabolic and endocrine disorders, including non-alcoholic steatohepatitis (NASH), hip fracture recovery, and type 2 diabetes.VKTX Viking Therapeutics Inc Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021

Viking Therapeutics Inc (NASDAQ:VKTX)’s Major holders. Insiders own 5.89% of the company shares, while shares held by institutions stand at 68.75% with a share float percentage of 73.05%. Investors are also buoyed by the number of investors in a company, with Viking Therapeutics Inc having a total of 246 institutions that hold shares in the ...

Viking Therapeutics Description. Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and ...

Market Cap. $1.3B. Currency in USD. Quote data delayed by at least 15 minutes. VKTX data by YCharts. Which low-priced healthcare stocks might be the next big movers? Wall Street analysts think Agenus ( AGEN 1.60% ) and Aclaris Therapeutics ( ACRS 3.01% ) could deliver market ...Find the latest Financials data for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. Strong Quarter-End Cash Position of $393M. SAN DIEGO, July 26, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the ...Viking Therapeutics, Inc. Common Stock (VKTX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

The latest price target for . Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on Monday, October 2, 2023.The analyst firm set a price target for 32.00 expecting VKTX to rise ...

NAV / 1-Day Return 392.46 / 0.42 %. Total Assets 2.7 Bil. Adj. Expense Ratio 0.080%. Expense Ratio 0.080%. Distribution Fee Level Low. Share Class Type Institutional. Category Large Blend ...

Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company presented new data from its Phase 2b studyA high-level overview of Viking Therapeutics, Inc. (VKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Dec 4, 2023 · The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on December 4, 2023.The analyst firm set a price target for $32.00 expecting VKTX to rise to within ... Fintel reports that on August 8, 2023, Stifel reiterated coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation.. Analyst Price Forecast Suggests 142.45% Upside. As of August 2 ...VKTX soared on obesity data, while Incyte INCY suffered a setback for ruxolitinib extended-release ... The Nasdaq Biotechnology Index has gained 0.68% in the past five trading sessions. Among the ...Impinj (PI) and Ambarella (AMBA) stocks are trading lower, while Viking Therapeutics (VKTX) is soaring after its public offering

May 11, 2023 · As of May 11, 2023, the average one-year price target for Viking Therapeutics is 29.89. The forecasts range from a low of 23.23 to a high of $36.75. The average price target represents an increase ... Курс акций Viking Therapeutics Inc (VKTX). NASDAQ: VKTX. Покупаете или продаете акции, которые котируются в валюте, отличной от местной?Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced... Oct 25, 202316 hours ago · He does not neglect the obesity-centered candidate VK2735, however, and writes, “We view VKTX’s lead candidate THR-β agonist VK2809 for NASH as similar to Madrigal Pharmaceutical’s MGL-3196 ... Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Viking Therapeutics Inc (Symbol: VKTX), where a total of 11,518 contracts have traded ...Fintel reports that on August 8, 2023, Stifel reiterated coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation.. Analyst Price Forecast Suggests 142.45% Upside. As of August 2 ...

Market Cap. $1.3B. Currency in USD. Quote data delayed by at least 15 minutes.

VKTX NASDAQ. VKTX NASDAQ. VKTX NASDAQ. Market closed Market closed. No trades. See on Supercharts. Overview News Ideas Financials Technicals . Forecast . Price target. 33.80 0.00 0.00%. The 10 analysts offering 1 year price forecasts for VKTX have a max estimate of — and a min estimate of —.May 16 (Reuters) - Viking Therapeutics Inc VKTX.O said on Tuesday its experimental drug, VK2809, met the main goal of a mid-stage trial to treat patients with a type of fatty liver disease.Fintel reports that on May 8, 2023, HC Wainwright & Co. reiterated coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation. Analyst Price Forecast Suggests 20.92% Upside. As of ...Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment ofSee the latest Viking Therapeutics Inc stock price (VKTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Viking Therapeutics last announced its quarterly earnings data on October 25th, 2023. The biotechnology company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.22) by $0.01. Viking Therapeutics has generated ($0.93) earnings per share over the last year ( ($0.93) diluted earnings per share).VKTX Viking Therapeutics Inc Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021Below is Validea's guru fundamental report for VIKING THERAPEUTICS INC (VKTX). Of the 22 guru strategies we follow, VKTX rates highest using our Quantitative Momentum Investor model based on the ...

Novavax Stock Is Going to Recover, Says 5-Star Analyst. After a disastrous 2022 impacted by underwhelming sales of its Covid-19 vaccine NVX-CoV2373, which saw the shares lose a brutal 93% of their ...

As of February 3, 2023, the average one-year price target for Viking Therapeutics is $18.70. The forecasts range from a low of $11.11 to a high of $31.50. The average price target represents an ...

Viking Therapeutics Inc stock price (VKTX) NASDAQ: VKTX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Viking Therapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Viking Therapeutics (VKTX 4.42%), a small-cap biotech, has been on quite the ride over the past few months.Thanks to a positive late-stage trial in nonalcoholic steatohepatitis (NASH) from rival ...VKTX NASDAQ: $20: $7-9 2,500,000: Laidlaw & Company: Developing drugs to speed hip fracture recovery and treat various metabolic disorders. Click to enlarge. IPO pipeline update.View Viking Therapeutics, Inc VKTX investment & stock information. Get the latest Viking Therapeutics, Inc VKTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.VIKING THERAPEUTICS INC ( VKTX) is a small-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 94% based on the firm’s underlying fundamentals and the stock ...Real time Viking Therapeutics (VKTX) stock price quote, stock graph, news & analysis.In the news. Yahoo Finance. 3 days ago. Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 74% of the company. Xem thông tin chi tiết về Cổ Phiếu Viking Therapeutics Inc (Chứng khoán VKTX) gồm Giá, Biểu Đồ, Phân Tích Kỹ Thuật, dữ liệu Lịch Sử, Báo Cáo về Viking Therapeutics Inc và hơn thế nữa. ... NASDAQ. Tiền tệ tính theo USD. Miễn trừ Trách nhiệm. Thêm vào Danh Mục. 11.350-0.420 (-3.57 % ...

Fintel reports that on May 16, 2023, BTIG maintained coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation.. Analyst Price Forecast Suggests 35.91% Upside. As of May 11, 2023 ...He does not neglect the obesity-centered candidate VK2735, however, and writes, “We view VKTX’s lead candidate THR-β agonist VK2809 for NASH as similar to Madrigal Pharmaceutical’s MGL-3196 ...Clinical-stage biotech Viking Therapeutics (NASDAQ:VKTX) added 15% on Monday after Roche (OTCQX:RHHBY) agreed to acquire a peer obesity drugmaker Carmot Therapeutics in a up to $3.1B deal. Viking ... Viking Therapeutics, Inc. Common Stock (VKTX) Stock Price, Quote, News & History | Nasdaq MY QUOTES: VKTX Edit my quotes Viking Therapeutics, Inc. Common Stock (VKTX) 0 Add to Watchlist Add...Instagram:https://instagram. third world war newsdraftkings competitorbest forex brokers for us tradersbest paper trade platform NASDAQ:VKTX 13.01. 0.79 (6.46%) 1d Financials Technical Analysis 1w 1m 6m 1y Interactive chart Dec 1, 2023, 9:00 pm 0 This is a Panic-proof Portfolio opinion which is available only for Premium members Curated by Michael O'Reilly since 2020. 1550+ opinions with 4.81 rating (one of ... hon hai stocklist of uranium stocks Find the latest Financials data for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. At Stock Options Channel, our YieldBoost formula has looked up and down the VKTX options chain for the new August 11th contracts and identified one put and one call contract of particular interest ... best retirement annuity Viking Therapeutics, Inc. Common Stock (VKTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Viking Therapeutics, Inc. (VKTX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 13.01 +0.79 (+6.46%) At close: 04:00PM EST 13.10 +0.09 (+0.69%) After hours: 07:47PM EST...